トランフェクション技術市場レポート：2030年までの動向、予測、競合分析

トランフェクション技術の動向と予測

世界のトランスフェクション技術市場は、2024年から2030年までのCAGRが7.1%で、2030年までに推定27億米ドルに達すると予想されています。この市場の主な促進要因は、慢性疾患の有病率の増加と細胞ベースの治療への投資の増加です。世界のトランスフェクション技術市場の将来は、治療薬デリバリー、生物医学研究、タンパク質生産市場にビジネスチャンスがあり、有望視されています。

トランスフェクション技術市場の洞察

Lucintel社は、試薬ベースの方法が予測期間中に高い成長を遂げると予測しています。

バイオ医療研究は予測期間中に最も高い成長が見込まれます。

北米は、感染症の流行、セルベース製品の使用の増加、主要企業の存在により、予測期間中に最も高い成長が見込まれます。

本レポートでは、以下の11の主要な質問に回答している：

• Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
• Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
• Q.3.今後成長が加速すると思われる地域とその理由は？
• Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
• Q.5.この市場におけるビジネスリスクと競合の脅威は？
• Q.6.この市場における新たな動向とその理由は？
• Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
• Q.8.この市場における新たな開発と、その開発をリードしている企業は？
• Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
• Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
• Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界のトランスフェクション技術市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界のトランスフェクション技術市場動向（2018-2023）と予測（2024-2030）
• 方法別の世界のトランスフェクション技術市場
  • 試薬ベースの方法
  • 機器ベースの方法
  • その他
• 技術別の世界のトランスフェクション技術市場
  • 物理的トランスフェクション
  • 生化学に基づくトランスフェクション
  • ウイルスベクターベースのトランスフェクション
• アプリケーション別の世界のトランスフェクション技術市場
  • 治療の送達
  • バイオメディカル調査
  • タンパク質の生産
• 最終用途別の世界のトランスフェクション技術市場
  • 研究センターと学術機関
  • 病院と診療所
  • 製薬会社およびバイオテクノロジー会社
  • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界のトランスフェクション技術市場
• 北米のトランスフェクション技術市場
• 欧州のトランスフェクション技術市場
• アジア太平洋トランスフェクション技術市場
• その他地域トランスフェクション技術市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • 方法別の世界のトランスフェクション技術市場の成長機会
  • 技術別の世界のトランスフェクション技術市場の成長機会
  • アプリケーション別の世界のトランスフェクション技術市場の成長機会
  • 最終用途別の世界のトランスフェクション技術市場の成長機会
  • 地域別の世界のトランスフェクション技術市場の成長機会
• 世界のトランスフェクション技術市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界のトランスフェクション技術市場の能力拡大
  • 世界のトランスフェクション技術市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Life Technologies
• Sigma Aldrich
• Lonza
• Promega
• Qiagen
• Bio-Rad
• Roche
• Polyplus Transfection
• Mirius Bio
• Maxcyte

Tranfection Technology Trends and Forecast

The future of the global tranfection technology market looks promising with opportunities in the therapeutic delivery, bio-medical research, and protein production markets. The global tranfection technology market is expected to reach an estimated $2.7 billion by 2030 with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are growing prevalence of chronic diseases and rising investment in cell-based therapies.

A more than 150-page report is developed to help in your business decisions.

Tranfection Technology by Segment

The study includes a forecast for the global tranfection technology by method, technology, application, end use, and region.

Tranfection Technology Market by Method [Shipment Analysis by Value from 2018 to 2030]:

• Reagent-Based Method
• Instrument-Based Method
• Others

Tranfection Technology Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Physical Transfection
• Biochemical Based Transfection
• Viral-Vector Based Transfection

Tranfection Technology Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Therapeutic Delivery
• Bio-Medical Research
• Protein Production

Tranfection Technology Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Research Centers and Academic Institutes
• Hospitals and Clinics
• Pharmaceutical and Biotechnology Companies
• Others

Tranfection Technology Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Tranfection Technology Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies tranfection technology companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the tranfection technology companies profiled in this report include-

• Life Technologies
• Sigma Aldrich
• Lonza
• Promega
• Qiagen
• Bio-Rad
• Roche
• Polyplus Transfection
• Mirius Bio
• Maxcyte

Tranfection Technology Market Insights

Lucintel forecasts that reagent-based method is expected to witness higher growth over the forecast period.

Bio-medical research is expected to witness highest growth over the forecast period.

North America is expected to witness highest growth over the forecast period due to rising prevalence of infectious diseases, growing use of cell-based products, and presence of key players in the region.

Features of the Global Tranfection Technology Market

Market Size Estimates: Tranfection technology market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Tranfection technology market by various segments, such as by method, technology, application, end use, and region. in terms of($B).

Regional Analysis: Tranfection technology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different methods, technologies, applications, end uses, and region.s for the tranfection technology market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the tranfection technology market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the tranfection technology market size?

Answer: The global tranfection technology market is expected to reach an estimated $2.7 billion by 2030.

Q.2. What is the growth forecast for tranfection technology market?

Answer: The global tranfection technology market is expected to grow with a CAGR of 7.1% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the tranfection technology market?

Answer: The major drivers for this market are growing prevalence of chronic diseases and rising investment in cell-based therapies.

Q.4. What are the major segments for tranfection technology market?

Answer: The future of the tranfection technology market looks promising with opportunities in the therapeutic delivery, bio-medical research, and protein production markets.

Q.5. Who are the key tranfection technology market companies?

Answer: Some of the key tranfection technology companies are as follows:

• Life Technologies
• Sigma Aldrich
• Lonza
• Promega
• Qiagen
• Bio-Rad
• Roche
• Polyplus Transfection
• Mirius Bio
• Maxcyte

Q.6. Which tranfection technology market segment will be the largest in future?

Answer: Lucintel forecasts that reagent-based method is expected to witness higher growth over the forecast period.

Q.7. In tranfection technology market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to rising prevalence of infectious diseases, growing use of cell-based products, and presence of key players in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the tranfection technology market by method (reagent-based method, instrument-based method, and others), technology (physical transfection, biochemical based transfection, and viral-vector based transfection), application (therapeutic delivery, bio-medical research, and protein production), end use (research centers and academic institutes, hospitals and clinics, pharmaceutical & biotechnology companies, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Tranfection Technology Market: Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Tranfection Technology Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Tranfection Technology Market by Method
  • 3.3.1: Reagent-Based Method
  • 3.3.2: Instrument-Based Method
  • 3.3.3: Others
• 3.4: Global Tranfection Technology Market by Technology
  • 3.4.1: Physical Transfection
  • 3.4.2: Biochemical Based Transfection
  • 3.4.3: Viral-Vector Based Transfection
• 3.5: Global Tranfection Technology Market by Application
  • 3.5.1: Therapeutic Delivery
  • 3.5.2: Bio-Medical Research
  • 3.5.3: Protein Production
• 3.6: Global Tranfection Technology Market by End Use
  • 3.6.1: Research Centers and Academic Institutes
  • 3.6.2: Hospitals and Clinics
  • 3.6.3: Pharmaceutical and Biotechnology Companies
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Tranfection Technology Market by Region
• 4.2: North American Tranfection Technology Market
  • 4.2.2: North American Tranfection Technology Market by Application: Therapeutic Delivery, Bio-Medical Research, and Protein Production
• 4.3: European Tranfection Technology Market
  • 4.3.1: European Tranfection Technology Market by Method: Reagent-Based Method, Instrument-Based Method, and Others
  • 4.3.2: European Tranfection Technology Market by Application: Therapeutic Delivery, Bio-Medical Research, and Protein Production
• 4.4: APAC Tranfection Technology Market
  • 4.4.1: APAC Tranfection Technology Market by Method: Reagent-Based Method, Instrument-Based Method, and Others
  • 4.4.2: APAC Tranfection Technology Market by Application: Therapeutic Delivery, Bio-Medical Research, and Protein Production
• 4.5: ROW Tranfection Technology Market
  • 4.5.1: ROW Tranfection Technology Market by Method: Reagent-Based Method, Instrument-Based Method, and Others
  • 4.5.2: ROW Tranfection Technology Market by Application: Therapeutic Delivery, Bio-Medical Research, and Protein Production

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Tranfection Technology Market by Method
  • 6.1.2: Growth Opportunities for the Global Tranfection Technology Market by Technology
  • 6.1.3: Growth Opportunities for the Global Tranfection Technology Market by Application
  • 6.1.4: Growth Opportunities for the Global Tranfection Technology Market by End Use
  • 6.1.5: Growth Opportunities for the Global Tranfection Technology Market by Region
• 6.2: Emerging Trends in the Global Tranfection Technology Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Tranfection Technology Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Tranfection Technology Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Life Technologies
• 7.2: Sigma Aldrich
• 7.3: Lonza
• 7.4: Promega
• 7.5: Qiagen
• 7.6: Bio-Rad
• 7.7: Roche
• 7.8: Polyplus Transfection
• 7.9: Mirius Bio
• 7.10: Maxcyte